The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Nightstar Therapeutics PLC

Nasdaq: NITE
Last

(U.S.) $19.00

Today's change-0.10 -0.52%
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.
 

Nightstar Therapeutics PLC

Nasdaq: NITE
Last

(U.S.) $19.00

Today's change-0.10 -0.52%
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.

Nightstar Therapeutics PLC down (U.S.)$0.10

Nightstar Therapeutics PLC closed lower Friday, dropping (U.S.)$0.10 or 0.52% to (U.S.)$19.00. Over the last five days, shares have gained 3.09%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 0.00% during the last year.

Key company metrics

  • Open(U.S.) $19.10
  • Previous close(U.S.) $19.10
  • High(U.S.) $19.15
  • Low(U.S.) $18.77
  • Bid / Ask(U.S.) $0.00 / (U.S.) $20.00
  • YTD % change--
  • Volume58,278
  • Average volume (10-day)96,904
  • Average volume (1-month)--
  • Average volume (3-month)--
  • 52-week range(U.S.) $14.56 to (U.S.) $24.94
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.50
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.

Latest Company News

    No News Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q4/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Dec 31, 201612/31/2016Jun 30, 201606/30/2016
Revenue------
Total other revenue------
Total revenue000
Gross profit------
Total cost of revenue------
Total operating expense8126
Selling / general / administrative121
Research & development6105
Depreciation / amortization------
Interest expense (income), net operating------
Unusual expense (income)------
Other operating expenses, total------
Operating income-8-12-6
Interest income (expense), net non-operating------
Gain (loss) on sale of assets------
Other------
Income before tax-8-12-6
Income after tax-8-12-6
Income tax, total------
Net income-8-12-6
Total adjustments to net income------
Net income before extra. items-8-12-6
Minority interest------
Equity in affiliates------
U.S. GAAP adjustment------
Inc. avail. to common excl. extra. items-8-12-6
Inc. avail. to common incl. extra. items-8-12-6
Diluted net income-8-12-6
Dilution adjustment000
Diluted weighted average shares282828
Diluted EPS excluding extraordinary itemsvalue per share-0.27-0.43-0.21
Dividends per sharevalue per share0.00--0.00
Diluted normalized EPSvalue per share-0.27-0.43-0.21